{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:00:46Z","timestamp":1758052846452,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.clinbiochem.2004.05.023","type":"journal-article","created":{"date-parts":[[2004,7,6]],"date-time":"2004-07-06T11:17:14Z","timestamp":1089112634000},"page":"898-903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?"],"prefix":"10.1016","volume":"37","author":[{"given":"Peter S.","family":"Bunting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB1","unstructured":"Canadian Cancer Statistics National Cancer Institute of Canada; 2003 p 18. Table 1."},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB2","unstructured":"Canadian Cancer Statistics. National Cancer Institute of Canada; 2003. p. 37. Fig. 3.1."},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0022-5347(17)37402-5","article-title":"Serum prostate-specific antigen as a prescreening test for prostate cancer","volume":"147","author":"Labrie","year":"1992","journal-title":"J. Urol"},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB4","first-page":"617","article-title":"Prostate cancer trends in Canada: rising incidence or increased detection?","volume":"149","author":"Levy","year":"1993","journal-title":"Can. Med. Assoc. J"},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB5","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.1995.03530180039027","article-title":"Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing","volume":"271","author":"Jacobsen","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0022-5347(05)67144-3","article-title":"Prostate specific antigen testing and ditigal rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam","volume":"164","author":"Beemsterboer","year":"2000","journal-title":"J. Urol"},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB7","first-page":"79","article-title":"Prostate cancer in Saskatchewan Canada, before and during the PSA era","volume":"11","author":"Skarsgard","year":"2000","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB8","unstructured":"The PSA test in the early detection of prostate cancer. Final report, February 1995. Health Services Utilization and Research Commission, Government of Saskatchewan."},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB9","unstructured":"Screening for cancer of the prostate: an evaluation of benefits, unwanted health effects, and costs. Report prepared by Conseil d'evaluation des technologies de la sante du Quebec; August 1995."},{"issue":"5","key":"10.1016\/j.clinbiochem.2004.05.023_BIB10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF03403900","article-title":"Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization and future intentions","volume":"88","author":"Mercer","year":"1997","journal-title":"Can. J. Public Health"},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB11","first-page":"111","article-title":"Prevalence of PSA testing and effect of clinical indications on patterns of PSA testing in a population-based sample of Alberta men","volume":"23","author":"McGregor","year":"2002","journal-title":"Chronic Dis. Can"},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB12","unstructured":"American Cancer Society web site; 2001. www.cancer.org."},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB13","unstructured":"American Urological Association web site; 2001. www.auanet.org."},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB14","unstructured":"Canadian Urological Association web site 2001. www.cua.org."},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB15","unstructured":"Canadian Prostate Cancer Network, Prostate Cancer Archives. www.cpcn.org\/archives\/2003_03_01."},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0009-8981(01)00717-3","article-title":"Screening for prostate cancer with prostate-specific antigen: beware the biases","volume":"315","author":"Bunting","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB17","unstructured":"American Urological Association. Prostate-specific antigen (PSA) best practice policy. Oncology 2000;14:267\u201372, 277\u201380."},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB18","first-page":"8","article-title":"American Cancer Society guidelines for the early detection of cancer","volume":"52","author":"Smith","year":"2002","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2105\/AJPH.93.5.779","article-title":"Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?","volume":"93","author":"Chan","year":"2003","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0009-9120(97)00141-0","article-title":"Laboratory survey of prostate-specific antigen testing in Ontario","volume":"31","author":"Bunting","year":"1998","journal-title":"Clin. Biochem"},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0009-9120(98)00052-6","article-title":"Prostate-specific antigen utilization in Ontario: extent of testing in patients with and without cancer","volume":"31","author":"Bunting","year":"1998","journal-title":"Clin. Biochem"},{"key":"10.1016\/j.clinbiochem.2004.05.023_BIB22","first-page":"70","article-title":"Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer","volume":"160","author":"Bunting","year":"1999","journal-title":"CMAJ"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912004001468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912004001468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:17:45Z","timestamp":1757863065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912004001468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0009912004001468"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.05.023","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}